Insider · CIK 0001325168
An Evelyn D
Files at BLZE (Backblaze, Inc.), MTNB (Matinas BioPharma Holdings, Inc.). First filing -, latest -.
An Evelyn D files SEC Form 4 as director at BLZE (Backblaze, Inc.), and also at MTNB (Matinas BioPharma Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; An Evelyn D has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | BLZE Backblaze, Inc. | AGrant or award Class A Common Stock | +19,306 | $0.00 | $0 | 118,307 | Jun 1, 2026 |
| May 27, 2025 | BLZE Backblaze, Inc. | AGrant or award Class A Common Stock | +25,210 | $0.00 | $0 | 99,001 | May 29, 2025 |
| Apr 30, 2025 | MTNB Matinas BioPharma Holdings, Inc. | AGrant or award Stock Option (right to Buy)derivative | +11,600 | $0.00 | $0 | 11,600 | May 2, 2025 |
Questions about An Evelyn D
Answered from the filings on this page, as of the latest one.
Is An Evelyn D buying or selling?
An Evelyn D has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did An Evelyn D's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and An Evelyn D has 0.
Where does An Evelyn D file Form 4?
An Evelyn D has filed Form 4 at BLZE (Backblaze, Inc.); MTNB (Matinas BioPharma Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.